BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16127553)

  • 1. Does the panic attack activate the hypothalamic-pituitary-adrenal axis?
    Graeff FG; Garcia-Leal C; Del-Ben CM; Guimarães FS
    An Acad Bras Cienc; 2005 Sep; 77(3):477-91. PubMed ID: 16127553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anxiety, panic and the hypothalamic-pituitary-adrenal axis].
    Graeff FG
    Braz J Psychiatry; 2007 May; 29 Suppl 1():S3-6. PubMed ID: 17546345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of specific association between panicogenic properties of caffeine and HPA-axis activation. A placebo-controlled study of caffeine challenge in patients with panic disorder.
    Masdrakis VG; Markianos M; Oulis P
    Psychiatry Res; 2015 Sep; 229(1-2):75-81. PubMed ID: 26243374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panic induced by carbon dioxide inhalation and lack of hypothalamic-pituitary-adrenal axis activation.
    Sinha SS; Coplan JD; Pine DS; Martinez JA; Klein DF; Gorman JM
    Psychiatry Res; 1999 May; 86(2):93-8. PubMed ID: 10397411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
    Abelson JL; Liberzon I; Young EA; Khan S
    Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPA axis activity in patients with panic disorder: review and synthesis of four studies.
    Abelson JL; Khan S; Liberzon I; Young EA
    Depress Anxiety; 2007; 24(1):66-76. PubMed ID: 16845643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol as an indicator of hypothalmic-pitituary-adrenal axis dysregulation in patients with panic disorder: a literature review.
    Jakuszkowiak-Wojten K; Landowski J; Wiglusz MS; Cubała WJ
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S445-51. PubMed ID: 26417813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology.
    Abelson JL; Nesse RM; Vinik AI
    Biol Psychiatry; 1994 Jul; 36(2):84-96. PubMed ID: 7524696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol.
    Abelson JL; Curtis GC
    Arch Gen Psychiatry; 1996 Apr; 53(4):323-31. PubMed ID: 8634010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol.
    Abelson JL; Curtis GC; Cameron OG
    J Psychiatr Res; 1996; 30(2):79-93. PubMed ID: 8816303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of stress on salivary cortisol in panic disorder patients.
    Stones A; Groome D; Perry D; Hucklebridge F; Evans P
    J Affect Disord; 1999; 52(1-3):197-201. PubMed ID: 10357033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary cortisol in panic: are males more vulnerable?
    van Duinen MA; Schruers KR; Jaegers E; Maes M; Griez EJ
    Neuro Endocrinol Lett; 2004 Oct; 25(5):386-90. PubMed ID: 15580175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the cortisol synthesis inhibitor metyrapone on the response to carbon dioxide challenge in panic disorder.
    Belgorodsky A; Knyazhansky L; Loewenthal U; Arbelle J; Cohen H; Benjamin J
    Depress Anxiety; 2005; 21(3):143-8. PubMed ID: 16001448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CO2 challenge results in hypothalamic-pituitary-adrenal activation in healthy volunteers.
    van Duinen MA; Schruers KR; Maes M; Griez EJ
    J Psychopharmacol; 2005 May; 19(3):243-7. PubMed ID: 15888509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-pituitary-adrenal axis activity in panic disorder: prediction of long-term outcome by pretreatment cortisol levels.
    Abelson JL; Curtis GC
    Am J Psychiatry; 1996 Jan; 153(1):69-73. PubMed ID: 8540595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A striking pattern of cortisol non-responsiveness to psychosocial stress in patients with panic disorder with concurrent normal cortisol awakening responses.
    Petrowski K; Herold U; Joraschky P; Wittchen HU; Kirschbaum C
    Psychoneuroendocrinology; 2010 Apr; 35(3):414-21. PubMed ID: 19913360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder.
    Erhardt A; Ising M; Unschuld PG; Kern N; Lucae S; Pütz B; Uhr M; Binder EB; Holsboer F; Keck ME
    Neuropsychopharmacology; 2006 Nov; 31(11):2515-22. PubMed ID: 16841071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Early Life Stress in HPA Axis and Anxiety.
    Juruena MF; Eror F; Cleare AJ; Young AH
    Adv Exp Med Biol; 2020; 1191():141-153. PubMed ID: 32002927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.